147 related articles for article (PubMed ID: 30298719)
41. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
[TBL] [Abstract][Full Text] [Related]
42. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents.
Li YC; Park MJ; Ye SK; Kim CW; Kim YN
Am J Pathol; 2006 Apr; 168(4):1107-18; quiz 1404-5. PubMed ID: 16565487
[TBL] [Abstract][Full Text] [Related]
43. Surface Engineered Protein Nanoparticles With Hyaluronic Acid Based Multilayers For Targeted Delivery Of Anticancer Agents.
Pulakkat S; Balaji SA; Rangarajan A; Raichur AM
ACS Appl Mater Interfaces; 2016 Sep; 8(36):23437-49. PubMed ID: 27560126
[TBL] [Abstract][Full Text] [Related]
44. EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo.
Chen J; Ouyang J; Chen Q; Deng C; Meng F; Zhang J; Cheng R; Lan Q; Zhong Z
ACS Appl Mater Interfaces; 2017 Jul; 9(28):24140-24147. PubMed ID: 28675028
[TBL] [Abstract][Full Text] [Related]
45. Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells.
Yan S; Qu X; Xu L; Che X; Ma Y; Zhang L; Teng Y; Zou H; Liu Y
Anticancer Drugs; 2014 Jul; 25(6):683-9. PubMed ID: 24710190
[TBL] [Abstract][Full Text] [Related]
46. Smart hyaluronidase-actived theranostic micelles for dual-modal imaging guided photodynamic therapy.
Li W; Zheng C; Pan Z; Chen C; Hu D; Gao G; Kang S; Cui H; Gong P; Cai L
Biomaterials; 2016 Sep; 101():10-9. PubMed ID: 27262027
[TBL] [Abstract][Full Text] [Related]
47. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
48. Inclusion complex from cyclodextrin-grafted hyaluronic acid and pseudo protein as biodegradable nano-delivery vehicle for gambogic acid.
Ji Y; Shan S; He M; Chu CC
Acta Biomater; 2017 Oct; 62():234-245. PubMed ID: 28859900
[TBL] [Abstract][Full Text] [Related]
49. Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
Shi S; Zhou M; Li X; Hu M; Li C; Li M; Sheng F; Li Z; Wu G; Luo M; Cui H; Li Z; Fu R; Xiang M; Xu J; Zhang Q; Lu L
J Control Release; 2016 Aug; 235():1-13. PubMed ID: 27235150
[TBL] [Abstract][Full Text] [Related]
50. Anti-tumor efficacy of hyaluronan-based nanoparticles for the co-delivery of drugs in lung cancer.
Jeannot V; Gauche C; Mazzaferro S; Couvet M; Vanwonterghem L; Henry M; Didier C; Vollaire J; Josserand V; Coll JL; Schatz C; Lecommandoux S; Hurbin A
J Control Release; 2018 Apr; 275():117-128. PubMed ID: 29474960
[TBL] [Abstract][Full Text] [Related]
51. Tumor-specific penetrating peptides-functionalized hyaluronic acid-d-α-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers.
Liang DS; Su HT; Liu YJ; Wang AT; Qi XR
Biomaterials; 2015 Dec; 71():11-23. PubMed ID: 26310359
[TBL] [Abstract][Full Text] [Related]
52. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
53. Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection.
Baek JS; Kim JH; Park JS; Cho CW
Int J Nanomedicine; 2015; 10():5397-405. PubMed ID: 26347363
[TBL] [Abstract][Full Text] [Related]
54. Enhanced Targeted Delivery of Cyclodextrin-Based Supermolecules by Core-Shell Nanocapsules for Magnetothermal Chemotherapy.
Lin IC; Fang JH; Lin CT; Sung SY; Su YL; Hu SH
Macromol Biosci; 2016 Sep; 16(9):1273-86. PubMed ID: 27328404
[TBL] [Abstract][Full Text] [Related]
55. Photochemically triggered cytosolic drug delivery using pH-responsive hyaluronic acid nanoparticles for light-induced cancer therapy.
Lee CS; Na K
Biomacromolecules; 2014 Nov; 15(11):4228-38. PubMed ID: 25251731
[TBL] [Abstract][Full Text] [Related]
56. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
[TBL] [Abstract][Full Text] [Related]
57. Lipid rafts disruption induces apoptosis by attenuating expression of LRP6 and survivin in triple negative breast cancer.
Badana AK; Chintala M; Gavara MM; Naik S; Kumari S; Kappala VR; Iska BR; Malla RR
Biomed Pharmacother; 2018 Jan; 97():359-368. PubMed ID: 29091885
[TBL] [Abstract][Full Text] [Related]
58. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
[TBL] [Abstract][Full Text] [Related]
59. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
60. Membrane microdomain formation is crucial in epiboly during gastrulation of medaka.
Adachi T; Sato C; Kitajima K
Biochem Biophys Res Commun; 2007 Jul; 358(3):848-53. PubMed ID: 17511962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
